Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Immunotherapy Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
MERCK & CO, INC
ELI LILLY AND COMPANY
F HOFFMANN-LA ROCHE AG
SEATTLE GENETICS, INC
BRISTOL-MYERS SQUIBB
AMGEN INC
CELGENE CORPORATION
SPECTRUM PHARMACEUTICALS, INC
GLAXOSMITHKLINE PLC
By Type:
Interleukins
Interferon-Alpha
Vaccines
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Immunotherapy Drug Market Overview 2018-2029
-
1.1 China Immunotherapy Drug Industry Development Overview
-
1.2 China Immunotherapy Drug Industry Development History
-
1.3 China Immunotherapy Drug Industry Market Size (2018-2029)
-
1.4 China Immunotherapy Drug Market Analysis by Type from Production Side
-
1.4.1 China Immunotherapy Drug Production Volume, Production Value and Growth Rate of Interleukins (2018-2029)
-
1.4.2 China Immunotherapy Drug Production Volume, Production Value and Growth Rate of Interferon-Alpha (2018-2029)
-
1.4.3 China Immunotherapy Drug Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)
-
1.5 China Immunotherapy Drug Market Analysis by Application from Consumption End
-
1.5.1 China Immunotherapy Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Immunotherapy Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Immunotherapy Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Immunotherapy Drug Market Analysis by Region
-
1.6.1 North China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Immunotherapy Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Immunotherapy Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Immunotherapy Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Immunotherapy Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Immunotherapy Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Immunotherapy Drug Industry Development
Chapter 3 Immunotherapy DrugIndustry Chain Analysis
-
3.1 Immunotherapy Drug Industry Chain
-
3.2 Immunotherapy Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Immunotherapy Drug Market
-
3.3 Immunotherapy Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Immunotherapy Drug Market
Chapter 4 China Immunotherapy Drug Market, by Type
-
4.1 China Immunotherapy Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Immunotherapy Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Immunotherapy Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Immunotherapy Drug Production Volume and Growth Rate of Interleukins
-
4.5.2 China Immunotherapy Drug Production Volume and Growth Rate of Interferon-Alpha
-
4.5.3 China Immunotherapy Drug Production Volume and Growth Rate of Vaccines
Chapter 5 China Immunotherapy Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Immunotherapy Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Immunotherapy Drug Market Size and Growth Rate, by Application
-
5.5.1 China Immunotherapy Drug Market Size and Growth Rate of Application 1
-
5.5.2 China Immunotherapy Drug Market Size and Growth Rate of Application 2
-
5.5.3 China Immunotherapy Drug Market Size and Growth Rate of Application 3
Chapter 6 China Immunotherapy Drug Market, by Region
-
6.1 China Immunotherapy Drug Production Volume and Production Value, by Region
-
6.2 China Immunotherapy Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Immunotherapy Drug Market Analysis
-
7.1 North China Immunotherapy Drug Market, by Type
-
7.2 North China Immunotherapy Drug Market, by Application
Chapter 8 Central China Immunotherapy Drug Market Analysis
-
8.1 Central China Immunotherapy Drug Market, by Type
-
8.2 Central China Immunotherapy Drug Market, by Application
Chapter 9 South China Immunotherapy Drug Market Analysis
-
9.1 South China Immunotherapy Drug Market, by Type
-
9.2 South China Immunotherapy Drug Market, by Application
Chapter 10 East China Immunotherapy Drug Market Analysis
-
10.1 East China Immunotherapy Drug Market, by Type
-
10.2 East China Immunotherapy Drug Market, by Application
Chapter 11 Northeast China Immunotherapy Drug Market Analysis
-
11.1 Northeast China Immunotherapy Drug Market, by Type
-
11.2 Northeast China Immunotherapy Drug Market, by Application
Chapter 12 Southwest China Immunotherapy Drug Market Analysis
-
12.1 Southwest China Immunotherapy Drug Market, by Type
-
12.2 Southwest China Immunotherapy Drug Market, by Application
Chapter 13 Northwest China Immunotherapy Drug Market Analysis
-
13.1 Northwest China Immunotherapy Drug Market, by Type
-
13.2 Northwest China Immunotherapy Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 MERCK & CO, INC
-
14.1.1 MERCK & CO, INC Company Profile
-
14.1.2 MERCK & CO, INC Immunotherapy Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 ELI LILLY AND COMPANY
-
14.2.1 ELI LILLY AND COMPANY Company Profile
-
14.2.2 ELI LILLY AND COMPANY Immunotherapy Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 F HOFFMANN-LA ROCHE AG
-
14.3.1 F HOFFMANN-LA ROCHE AG Company Profile
-
14.3.2 F HOFFMANN-LA ROCHE AG Immunotherapy Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 SEATTLE GENETICS, INC
-
14.4.1 SEATTLE GENETICS, INC Company Profile
-
14.4.2 SEATTLE GENETICS, INC Immunotherapy Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 BRISTOL-MYERS SQUIBB
-
14.5.1 BRISTOL-MYERS SQUIBB Company Profile
-
14.5.2 BRISTOL-MYERS SQUIBB Immunotherapy Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 AMGEN INC
-
14.6.1 AMGEN INC Company Profile
-
14.6.2 AMGEN INC Immunotherapy Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 CELGENE CORPORATION
-
14.7.1 CELGENE CORPORATION Company Profile
-
14.7.2 CELGENE CORPORATION Immunotherapy Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 SPECTRUM PHARMACEUTICALS, INC
-
14.8.1 SPECTRUM PHARMACEUTICALS, INC Company Profile
-
14.8.2 SPECTRUM PHARMACEUTICALS, INC Immunotherapy Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 GLAXOSMITHKLINE PLC
-
14.9.1 GLAXOSMITHKLINE PLC Company Profile
-
14.9.2 GLAXOSMITHKLINE PLC Immunotherapy Drug Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Immunotherapy Drug Industry Research Conclusions
-
15.2 Immunotherapy Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Immunotherapy Drug Industry Market Size (2018-2029)
-
Figure China Immunotherapy Drug Production Volume, Production Value and Growth Rate of Interleukins (2018-2029)
-
Figure China Immunotherapy Drug Production Volume, Production Value and Growth Rate of Interferon-Alpha (2018-2029)
-
Figure China Immunotherapy Drug Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)
-
Figure China Immunotherapy Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Immunotherapy Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Immunotherapy Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Immunotherapy Drug Market Size and Growth Rate from 2018-2029
-
Figure Immunotherapy Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Immunotherapy Drug Market Share by Type in 2018
-
Figure China Immunotherapy Drug Market Share by Type in 2023
-
Figure China Immunotherapy Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Immunotherapy Drug Production Volume and Growth Rate of Interleukins (2018-2023)
-
Figure China Immunotherapy Drug Production Volume and Growth Rate of Interferon-Alpha (2018-2023)
-
Figure China Immunotherapy Drug Production Volume and Growth Rate of Vaccines (2018-2023)
-
Figure China Immunotherapy Drug Market Share by Application in 2018
-
Figure China Immunotherapy Drug Market Share by Application in 2023
-
Figure China Immunotherapy Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Immunotherapy Drug Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Immunotherapy Drug Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Immunotherapy Drug Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Immunotherapy Drug Production Volume by Region (2018-2023)
-
Table China Immunotherapy Drug Production Volume Share by Region (2018-2023)
-
Figure China Immunotherapy Drug Production Volume Share by Region (2018-2023)
-
Table China Immunotherapy Drug Production Value by Region (2018-2023)
-
Table China Immunotherapy Drug Production Value Share by Region (2018-2023)
-
Figure China Immunotherapy Drug Production Value Share by Region (2018-2023)
-
Table China Immunotherapy Drug Sales Volume by Region (2018-2023)
-
Table China Immunotherapy Drug Sales Volume Share by Region (2018-2023)
-
Figure China Immunotherapy Drug Sales Volume Share by Region (2018-2023)
-
Table China Immunotherapy Drug Sales Value by Region (2018-2023)
-
Table China Immunotherapy Drug Sales Value Share by Region (2018-2023)
-
Figure China Immunotherapy Drug Sales Value Share by Region (2018-2023)
-
Table North China Immunotherapy Drug Production Volume by Type (2018-2023)
-
Table North China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Figure North China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Table North China Immunotherapy Drug Sales Volume by Application (2018-2023)
-
Table North China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Immunotherapy Drug Production Volume by Type (2018-2023)
-
Table Central China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Table Central China Immunotherapy Drug Sales Volume by Application (2018-2023)
-
Table Central China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Table South China Immunotherapy Drug Production Volume by Type (2018-2023)
-
Table South China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Figure South China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Table South China Immunotherapy Drug Sales Volume by Application (2018-2023)
-
Table South China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Table East China Immunotherapy Drug Production Volume by Type (2018-2023)
-
Table East China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Figure East China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Table East China Immunotherapy Drug Sales Volume by Application (2018-2023)
-
Table East China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Immunotherapy Drug Production Volume by Type (2018-2023)
-
Table Northeast China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Immunotherapy Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Immunotherapy Drug Production Volume by Type (2018-2023)
-
Table Southwest China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Immunotherapy Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Immunotherapy Drug Production Volume by Type (2018-2023)
-
Table Northwest China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Immunotherapy Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Immunotherapy Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Immunotherapy Drug Sales Volume Share by Application (2018-2023)
-
Table MERCK & CO, INC Company Profile
-
Table MERCK & CO, INC Immunotherapy Drug Revenue, Price and Gross (2018-2023)
-
Table ELI LILLY AND COMPANY Company Profile
-
Table ELI LILLY AND COMPANY Immunotherapy Drug Revenue, Price and Gross (2018-2023)
-
Table F HOFFMANN-LA ROCHE AG Company Profile
-
Table F HOFFMANN-LA ROCHE AG Immunotherapy Drug Revenue, Price and Gross (2018-2023)
-
Table SEATTLE GENETICS, INC Company Profile
-
Table SEATTLE GENETICS, INC Immunotherapy Drug Revenue, Price and Gross (2018-2023)
-
Table BRISTOL-MYERS SQUIBB Company Profile
-
Table BRISTOL-MYERS SQUIBB Immunotherapy Drug Revenue, Price and Gross (2018-2023)
-
Table AMGEN INC Company Profile
-
Table AMGEN INC Immunotherapy Drug Revenue, Price and Gross (2018-2023)
-
Table CELGENE CORPORATION Company Profile
-
Table CELGENE CORPORATION Immunotherapy Drug Revenue, Price and Gross (2018-2023)
-
Table SPECTRUM PHARMACEUTICALS, INC Company Profile
-
Table SPECTRUM PHARMACEUTICALS, INC Immunotherapy Drug Revenue, Price and Gross (2018-2023)
-
Table GLAXOSMITHKLINE PLC Company Profile
-
Table GLAXOSMITHKLINE PLC Immunotherapy Drug Revenue, Price and Gross (2018-2023)
-
